Intuitive Surgical (NASDAQ:ISRG – Free Report) had its price objective increased by Wells Fargo & Company from $466.00 to $549.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock.
A number of other equities research analysts also recently commented on ISRG. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Leerink Partners lifted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Citigroup lifted their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Evercore ISI boosted their target price on Intuitive Surgical from $410.00 to $475.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $513.74.
View Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Trading Down 0.4 %
Insider Transactions at Intuitive Surgical
In related news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,655,048.26. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,902 shares of company stock worth $23,596,360 over the last three months. 0.90% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in ISRG. Creekmur Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth $26,000. Delos Wealth Advisors LLC lifted its stake in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. Finally, LRI Investments LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- What is a SEC Filing?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- What is the FTSE 100 index?
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Stock Analyst Ratings and Canadian Analyst Ratings
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.